THE FINANCIAL TIMES reports:
Mergers and acquisitions are Wall Street’s blood sport. Winning a deal is of paramount importance. So anyone who gets in the way of achieving that goal draws ire.
That is one reason why top US antitrust enforcer Lina Khan has become such an antagonist for dealmakers and why they were rejoicing this month when Amgen reached a settlement with her agency, allowing the pharmaceutical company’s $28bn acquisition …
The post FT: Banker glee does not tell the whole story on Lina Khan setbacks appeared first on The Loadstar.
